BCR-ABL tyrosine kinase inhibitors

475 Pill - yellow oval, 20mm

Pill with imprint 475 is Yellow, Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Sun Pharma Global FZE.

Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Acute Lymphoblastic Leukemia; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Imatinib (Imatinib [ im-ma-ta-nib ])-475-400 mg-Yellow-Oval
Imatinib (Imatinib [ im-ma-ta-nib ])-475-400 mg-Yellow-Oval

Imatinib
Generic Name: imatinib [ im-ma-ta-nib ]
Imprint: 475
Strength: 400 mg
Color: Yellow
Size: 20.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 47335-0475
Inactive Ingredients: Microcrystalline cellulose, Mannitol, Copovidone, Crospovidone, Magnesium stearate, Hypromelloses, Ferric oxide yellow, Polyethylene glycol, Titanium dioxide, FD&C Yellow No. 6, Ferric oxide red,
Latest News
Related Drugs